Leinco Technologies
Leinco Technologies, Inc. is a biotechnology company founded in 1992 as a specialty manufacturer of early discovery research products including antibodies, recombinant proteins, ELISA kits, second step reagents and other life sciences products. Shortly thereafter, Leinco also established themselves as a premier provider of custom R&D and manufacturing services focusing on monoclonal antibodies and recombinant proteins. Our innovative products and services are used to augment the early discovery process in life science research, diagnostics and ground breaking development of protein therapeutics.
Content by Leinco Technologies
|2 min read
Leinco Technologies Launches Novel COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Test Kit
This standard 96-well ELISA based assay is a game changer for evaluating convalescent plasma, antibody therapies and determining the effectiveness of vaccines for COVID-19
|2 min read
Leinco and Vanderbilt Partner on Rapid, Point of Care COVID-19 Diagnostic Test
Under the agreement, Leinco Technologies will co-develop a rapid, point of care, immunodiagnostic test for the detection of the SARS-CoV-2 virus responsible for COVID-19Page 1 of 1
